• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    UK Neurology Devices Market

    ID: MRFR/HC/50061-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    UK Neurology Devices Market Research Report By Product Type (neurostimulation, interventional neurology, CSF management, neurosurgery devices) and By End-user (hospitals & clinics, specialty center)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    UK Neurology Devices Market Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    UK Neurology Devices Market Summary

    The United Kingdom UK Neurology Devices market is projected to experience substantial growth over the next decade.

    Key Market Trends & Highlights

    UK Neurology Devices Key Trends and Highlights

    • The market valuation is expected to grow from 750 USD Million in 2024 to 1850 USD Million by 2035.
    • The compound annual growth rate (CAGR) for the period from 2025 to 2035 is estimated at 8.55 percent.
    • This growth trajectory indicates a robust expansion in the neurology devices sector within the UK.
    • Growing adoption of advanced neurology devices due to increasing prevalence of neurological disorders is a major market driver.

    Market Size & Forecast

    2024 Market Size 750 (USD Million)
    2035 Market Size 1850 (USD Million)
    CAGR (2025-2035) 8.55%

    Major Players

    Zimmer Biomet, Boston Scientific, Neuropace, Cleveland Medical Devices, ElectroCore, Janssen Pharmaceuticals, Abbott Laboratories, Neurotech, Medtronic, Cerebrotech Medical Systems, Aap Implantate AG, Stryker, Natus Medical, B. Braun, Teleflex

    UK Neurology Devices Market Trends

    The ageing population and rising incidence of neurological illnesses are driving significant developments in the UK neurology devices market. The need for cutting-edge diagnostic and treatment tools is being driven by the rise in diseases including epilepsy, Parkinson's disease, and dementia.

    The UK government is making significant investments in medical technology, supporting the creation of novel neurological tools, and incorporating them into pre-existing healthcare systems. Initiatives from the National Health Service (NHS) to enhance patient outcomes and care efficiency also have an impact on this boost.

    The increasing popularity of minimally invasive procedures and sophisticated imaging technologies, which improve the accuracy of diagnosis and treatment, present opportunities in the UK market.

    Additionally, the move to digital health solutions, such as telemedicine and remote monitoring tools, offers opportunities for better patient participation and management, particularly in the wake of COVID-19. Businesses who create neurological equipment with digital integration stand to gain a great deal.

    The emphasis on personalised medicine has grown recently, which has prompted device manufacturers to spend money on research and development to produce specialised treatments for people with certain neurological disorders. This trend is a result of cooperation between UK healthcare providers, universities, and research institutions.

    Furthermore, improvements in machine learning and artificial intelligence are changing the way neurology equipment work and providing chances for improved patient monitoring and data analysis, which will improve clinical results even more.

    With reduced procedures for introducing new products to the market, the UK's changing regulatory environment is also encouraging innovation, which will eventually benefit both patients and healthcare professionals.

    Market Segment Insights

    UK Neurology Devices Market Segment Insights

    UK Neurology Devices Market Segment Insights

    Neurology Devices Market Product Type Insights

    Neurology Devices Market Product Type Insights

    The UK Neurology Devices Market is characterized by its diverse Product Type segmentation, which includes neurostimulation, interventional neurology, cerebrospinal fluid (CSF) management, and neurosurgery devices. Neurostimulation has gained significant traction due to its effectiveness in treating various neurological disorders, making it a key driver in the market growth.

    The advancements in technology and techniques in this area have led to the development of innovative devices that are increasingly adopted within clinical settings. Interventional neurology is also pivotal, offering minimally invasive solutions to treat a range of conditions, thereby enhancing patient outcomes and reducing recovery times.

    This segment is becoming increasingly vital, particularly as the prevalence of stroke and other cognitive disorders rises within the UK population. CSF management devices play a crucial role in treating conditions associated with abnormal CSF dynamics, such as hydrocephalus, which has seen a rising number of cases.

    The efficiency and effectiveness of these devices have made them indispensable in neurocritical care settings. Lastly, neurosurgery devices contribute to the safety and efficacy of surgical procedures. This segment is essential as it supports complex surgical interventions, helping surgeons navigate intricate anatomical structures with precision.

    Neurology Devices Market

    Neurology Devices Market End-user Insights

    The UK Neurology Devices Market, particularly in the End-user segment, reveals vital dynamics influencing healthcare advancements in the region. Hospitals and clinics play a significant role, being primary beneficiaries of neurology devices, given their accessibility to a large patient base and advanced treatment facilities.

    These institutions witness a growing demand for diagnostic and therapeutic devices to cater to neurological disorders, which is further amplified by the increasing incidence of conditions such as epilepsy, multiple sclerosis, and Alzheimer's disease.

    Specialty centers are similarly crucial as they offer targeted care and specialized treatments, often housing advanced technologies, thus enhancing patient outcomes. The increasing emphasis on personalized medicine in these centers drives innovation and adoption of cutting-edge devices.

    Get more detailed insights about UK Neurology Devices Market Research Report- Forecast to 2035

    Key Players and Competitive Insights

    The UK Neurology Devices Market represents a dynamic and evolving space, characterized by rapid advancements in medical technology and an increasing demand for innovative solutions to neurological disorders.

    As healthcare providers aim to enhance patient outcomes and improve the quality of care, the competitive landscape has intensified, fostering a variety of strategic partnerships, product developments, and market entries.

    Companies operating in this market continuously strive to differentiate themselves through innovative product offerings, robust research and development initiatives, and effective marketing strategies. The presence of diverse players presents a comprehensive selection of devices, targeting conditions such as epilepsy, Parkinson's disease, and chronic migraine, thus highlighting the competitiveness of this sector.

    Zimmer Biomet holds a notable presence in the UK Neurology Devices Market, recognized for its commitment to advancing surgical and non-surgical treatment options in neurology. The company's strengths lie in its comprehensive portfolio of neuromodulation devices and advanced surgical tools that cater specifically to neurological conditions.

    Zimmer Biomet’s strategic approach involves significant investments in innovation, resulting in the development of cutting-edge technologies that enhance surgical efficiency and improve patient outcomes.

    Their focus on building robust relationships with healthcare professionals, alongside a strong distribution network, has positioned Zimmer Biomet as a trusted name in the UK market. Additionally, their ongoing initiatives in clinical research further exemplify their dedication to understanding patient needs and tailoring solutions accordingly.

    In the UK Neurology Devices Market, Boston Scientific stands out as a key player with a diverse range of products designed for treating neurological conditions. The company is particularly noted for its advanced neurostimulation devices and implantable systems that assist in managing chronic pain and movement disorders.

    Boston Scientific’s market presence is marked by its strong commitment to innovation, continually launching new products that address unmet medical needs in neurology. Their strengths include a robust pipeline of new technologies and strategic mergers and acquisitions that enhance their capabilities.

    The company actively collaborates with healthcare providers to ensure their products are aligned with clinical practices, which fosters trust and reliability in the UK market. Boston Scientific's dedication to improving patient care and its ability to adapt to evolving market demands underscore its competitive edge in the neurology device sector.

    Key Companies in the UK Neurology Devices Market market include

    Industry Developments

    The UK Neurology Devices Market has recently seen significant developments. In September 2023, Medtronic announced advancements in its deep brain stimulation systems, aimed at improving treatment outcomes for patients with neurological disorders.

    Meanwhile, Boston Scientific has made strides with its innovative stroke intervention devices, positioning itself for enhanced market penetration. In the same month, ElectroCore launched a new non-invasive vagus nerve stimulation device aimed at treating various chronic headaches, further diversifying its product offerings.

    Additionally, in August 2023, Cleveland Medical Devices secured a collaboration with Stryker to co-develop neuro-monitoring technologies that have the potential to reshape surgical practices in neurology. The market valuation for major companies like Abbott Laboratories and Natus Medical continues to grow, fueled by increased healthcare investments and a rising prevalence of neurological conditions within the UK.

    Significant happenings in recent years include Neurotech's expansion in March 2022 with new clinical trials for its neuromodulation therapies. Overall, the UK Neurology Devices Market is experiencing robust growth driven by innovation, collaborations, and a focus on improving patient outcomes.

    Market Segmentation

    Neurology Devices Market End-user Outlook

    • hospitals & clinics
    • specialty center

    Neurology Devices Market Product Type Outlook

    • neurostimulation
    • interventional neurology
    • CSF management
    • neurosurgery devices

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 654.84(USD Million)
    MARKET SIZE 2024 750.0(USD Million)
    MARKET SIZE 2035 1850.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 8.554% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Zimmer Biomet, Boston Scientific, Neuropace, Cleveland Medical Devices, ElectroCore, Janssen Pharmaceuticals, Abbott Laboratories, Neurotech, Medtronic, Cerebrotech Medical Systems, Aap Implantate AG, Stryker, Natus Medical, B. Braun, Teleflex
    SEGMENTS COVERED Product Type, End User
    KEY MARKET OPPORTUNITIES Telehealth integration, AI-driven diagnostics, Wearable monitoring devices, Enhanced surgical technologies, Patient-centric rehabilitation solutions
    KEY MARKET DYNAMICS Aging population increase, Rising neurological disorders, Advancements in technology, Government funding initiatives, Growing patient awareness
    COUNTRIES COVERED UK

    FAQs

    What is the expected market size of the UK Neurology Devices Market in 2024?

    The UK Neurology Devices Market is expected to be valued at 750.0 million USD in 2024.

    What will be the market size of the UK Neurology Devices Market by 2035?

    The market is projected to reach a value of 1850.0 million USD by 2035.

    What is the expected CAGR for the UK Neurology Devices Market from 2025 to 2035?

    The market is anticipated to grow at a CAGR of 8.554 percent during the period from 2025 to 2035.

    Which product type is the largest segment in the UK Neurology Devices Market in 2024?

    The neurosurgery devices segment is the largest, valued at 300.0 million USD in 2024.

    What market share does neurostimulation hold in 2024 within the UK Neurology Devices Market?

    The neurostimulation segment is valued at 200.0 million USD in 2024.

    Who are the major players in the UK Neurology Devices Market?

    Key players include Medtronic, Boston Scientific, and Abbott Laboratories among others.

    What growth is expected in the interventional neurology segment by 2035?

    The interventional neurology segment is expected to grow to 400.0 million USD by 2035.

    What challenges does the UK Neurology Devices Market currently face?

    Challenges include regulatory hurdles and the need for continuous innovation in device technology.

    What opportunities exist for growth in the UK Neurology Devices Market?

    The market offers opportunities through advances in neurostimulation technology and increasing demand for minimally invasive procedures.

    How much will the csf management segment be valued at by 2035?

    The csf management segment is projected to reach 250.0 million USD by 2035.

    UK Neurology Devices Market Research Report- Forecast to 2035 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Stories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study
    Chemicals and Materials